Cue Biopharma Stock (NASDAQ: CUE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 388.96K |
Day Range | - - - |
52 Wk Range | 0.73 - 4.65 |
Market Cap | $40.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 9.82% |
Days to Cover | 6.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.
Other companies in Cue Biopharma’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).
There is no analysis for Cue Biopharma.
Cue Biopharma has a consensus price target of $11.86.
The stock price for Cue Biopharma (NASDAQ: CUE) is $0.828 last updated July 19, 2024 at 7:40 PM EDT.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.